LXRX
LEXICON PHARMACEUTICALS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
LEXICON PHARMACEUTICALS INC (LXRX) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$29.11M; the largest are Steven Cohen, Ken Griffin, Izzy Englander. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 1 new, 2 added, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Mixed
Common-stock holders51 also report options
Congress trades0
Price$1.90vs quarter-end-20.83%
Sectors0
This quarter's moves
Top holderNew1
Added2
Trimmed / sold2
Steven CohenCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $886.3K— of portfolio369,3002026 Q2
Value $43.0K— of portfolio17,9002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $886.3K | — | — |
| Ken GriffinPUT | $43.0K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.